Distinct functions of Sox2 control self-renewal and differentiation in the osteoblast lineage

Molecular and Cellular Biology

Volumn 31, Issue 22, 2011, Pages 4593-4608

  Seo, Eunjeong ^a   Basu Roy, Upal ^a   Zavadil, Jiri ^a   Basilico, Claudio ^a   Mansukhani, Alka ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; APC PROTEIN; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN G; POLYCOMB GROUP PROTEIN; TRANSCRIPTION FACTOR SOX2; TUBULIN; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BMI 1 GENE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL LINEAGE; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; FOXP1 GENE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; OSTEOBLAST; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; BETA CATENIN; CELL CYCLE; CELL LINE; CELL PROLIFERATION; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; MICE; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; SKULL; SOXB1 TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 83255187897     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05798-11     Document Type: Article

References (56)

1. Ambrosetti, D., G. Holmes, A. Mansukhani, and C. Basilico. 2008. Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts. Mol. Cell. Biol. 28:4759-4771.
2. Ambrosetti, D. C., C. Basilico, and L. Dailey. 1997. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell. Biol. 17:6321-6329.
3. Ambrosetti, D. C., H. R. Scholer, L. Dailey, and C. Basilico. 2000. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J. Biol. Chem. 275:23387-23397.
4. Aubin, J., and J. Triffit. 2002. Mesenchymal cells and osteoblast differentiation, p. 59-82. In J. Bilezikian, L. G. Raisz, and G. A. Rodan, (ed.), Principles of bone biology, vol. 1. Academic Press, New York, NY.
5. Baron, R., and G. Rawadi. 2007. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148:2635-2643.
6. Basu-Roy, U., et al. 2010. The transcription factor Sox2 is required for osteoblast self-renewal. Cell Death Differ. 17:1345-1353.
7. Basu-Roy, U., et al. 19 September 2011. Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene doi:10.1038/onc.2011.405.
8. Beisel, C., and R. Paro. 2011. Silencing chromatin: comparing modes and mechanisms. Nat. Rev. Genet. 12:123-135.
9. Bennett, C. N., et al. 2005. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. U. S. A. 102:3324-3329.
10. Ben-Porath, I., et al. 2008. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40:499-507.
11. Bernard, P., and V. R. Harley. 2010. Acquisition of SOX transcription factor specificity through protein-protein interaction, modulation of Wnt signalling and post-translational modification. Int. J. Biochem. Cell Biol. 42:400-410.
12. Bhattacharya, R., et al. 2009. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 69:9090-9095.
13. Boyer, L. A., et al. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956.
14. Clevers, H. 2006. Wnt/beta-catenin signaling in development and disease. Cell 127:469-480.
15. Dailey, L., and C. Basilico. 2001. Coevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes. J. Cell. Physiol. 186:315-328.
16. Ellis, P., et al. 2004. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev. Neurosci. 26:148-165.
17. Gaur, T., et al. 2005. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280:33132-33140.
18. Harley, V. R., R. Lovell-Badge, and P. N. Goodfellow. 1994. Definition of a consensus DNA binding site for SRY. Nucleic Acids Res. 22:1500-1501.
19. Ismail, I. H., C. Andrin, D. McDonald, and M. J. Hendzel. 2010. BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. J. Cell Biol. 191:45-60.
20. Kamachi, Y., M. Uchikawa, and H. Kondoh. 2000. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet. 16:182-187.
21. Karsenty, G., H. M. Kronenberg, and C. Settembre. 2009. Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 25:629-648.
22. Krishnan, V., H. U. Bryant, and O. A. Macdougald. 2006. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116:1202-1209.
23. Lee, K. S., et al. 2000. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 20:8783-8792.
24. Lian, J. B., et al. 2006. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev. Endocr Metab. Disord. 7:1-16.
25. Liu, J., et al. 2009. Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature 459:387-392.
26. Mansukhani, A., D. Ambrosetti, G. Holmes, L. Cornivelli, and C. Basilico. 2005. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J. Cell Biol. 168:1065-1076.
27. Mansukhani, A., P. Bellosta, M. Sahni, and C. Basilico. 2000. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 149:1297-1308.
28. Marson, A., et al. 2008. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134:521-533.
29. Maruyama, T., A. J. Mirando, C. X. Deng, and W. Hsu. 2010. The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci. Signal. 3:ra40.
30. Memarzadeh, S., et al. 2007. Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell 12:572-585.
31. Molofsky, A. V., S. He, M. Bydon, S. J. Morrison, and R. Pardal. 2005. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 19:1432-1437.
32. Mootha, V. K., et al. 2003. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34:267-273.
33. Nakashima, K., et al. 2002. The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
34. Nakatake, Y., et al. 2006. Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol. Cell. Biol. 26:7772-7782.
35. Nelson, J. D., O. Denisenko, and K. Bomsztyk. 2006. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1:179-185.
36. Nelson, J. D., O. Denisenko, P. Sova, and K. Bomsztyk. 2006. Fast chromatin immunoprecipitation assay. Nucleic Acids Res. 34:e2.
37. Nichols, J., et al. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391.
38. Niwa, H. 2007. How is pluripotency determined and maintained? Development 134:635-646.
39. Nusse, R. 2005. Wnt signaling in disease and in development. Cell Res. 15:28-32.
40. Park, I. K., S. J. Morrison, and M. F. Clarke. 2004. Bmi1, stem cells, and senescence regulation. J. Clin. Invest. 113:175-179.
41. Pevny, L. H., and S. K. Nicolis. 2010. Sox2 roles in neural stem cells. Int. J. Biochem. Cell Biol. 42:421-424.
42. Pittenger, M. F., et al. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
43. Que, J., et al. 2007. Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development 134:2521-2531.
44. Rachner, T. D., S. Khosla, and L. C. Hofbauer. 2011. Osteoporosis: now and the future. Lancet 377:1276-1287.
45. Ramalho-Santos, M., S. Yoon, Y. Matsuzaki, R. C. Mulligan, and D. A. Melton. 2002. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298:597-600.
46. Sauvageau, M., and G. Sauvageau. 2010. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 7:299-313.
47. Subramanian, A., et al. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545-15550.
48. Surface, L. E., S. R. Thornton, and L. A. Boyer. 2010. Polycomb group proteins set the stage for early lineage commitment. Cell Stem Cell 7:288-298.
49. Takahashi, K., and S. Yamanaka. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
50. Takamiya, K., L. Mao, R. L. Huganir, and D. J. Linden. 2008. The glutamate receptor-interacting protein family of GluR2-binding proteins is required for long-term synaptic depression expression in cerebellar Purkinje cells. J. Neurosci. 28:5752-5755.
51. Taranova, O. V., et al. 2006. SOX2 is a dose-dependent regulator of retinal neural progenitor competence. Genes Dev. 20:1187-1202.
52. van de Wetering, M., and H. Clevers. 1992. Sequence-specific interaction of the HMG box proteins TCF-1 and SRY occurs within the minor groove of a Watson-Crick double helix. EMBO J. 11:3039-3044.
53. Vickers, E. R., and A. D. Sharrocks. 2002. The use of inducible engrailed fusion proteins to study the cellular functions of eukaryotic transcription factors. Methods 26:270-280.
54. Wegner, M. 2010. All purpose Sox: the many roles of Sox proteins in gene expression. Int. J. Biochem. Cell Biol. 42:381-390.
55. Yuan, H., N. Corbi, C. Basilico, and L. Dailey. 1995. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9:2635-2645.
56. Zhang, H. W., et al. 2010. Defects in mesenchymal stem cell self-renewal and cell fate determination lead to an osteopenic phenotype in Bmi-1 null mice. J. Bone Miner. Res. 25:640-652.